ReviewTranslational lung cancer research2025
The evolving role of wedge resection in early-stage non-small cell lung cancer: a literature review.
Review in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Minimally Invasive Sampling Techniques for Pancreatic and Pulmonary Nodules: A Review of the Evolution of Guidance and Sampling Methods.Diagnostic cytopathology · 2026Review
- Can the Cancer and Leukemia Group B 140503 trial support choice of segmental versus wedge resection for non-small cell lung cancer?JTCVS open · 2026Article
- Lobectomy, segmentectomy, and wedge resection for elderly patients with solid-predominant stage I NSCLC: survival, pulmonary function, and postoperative outcomes.Translational lung cancer research · 2026Article
- Ultrasound-Guided Cervical Vagus Nerve Block for Postoperative Opioid Consumption After Thoracoscopic Lung Surgery: Study Protocol for a Randomized Controlled Trial.Journal of pain research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: The surgical management of early-stage non-small cell lung cancer (NSCLC) is evolving due to advances in imaging, staging, and individualized patient selection. Although lobectomy has historically been the gold standard for stage I operable NSCLC, the detection of smaller peripheral tumors and minimally invasive techniques have revived interest in sublobar resections, especially wedge resection. This review aims to critically examine the current and potential role of wedge resection in this context. Methods: A narrative review was conducted using literature retrieved from PubMed, Scopus, and Google Scholar, covering the period from January 2000 to March 2024. Keywords included "non-small cell lung cancer", "wedge resection", "sublobar resection", and "early-stage lung cancer". Studies were selected based on relevance to surgical outcomes, recurrence, and evolving management strategies. Key Content and Findings: Wedge resection, traditionally reserved for high-risk or medically inoperable patients, has shown variable oncologic validity. Retrospective series, database analyses, and prospective trials, such as CALGB 140503, provide evidence for its selective use. However, segmentectomy appears to offer improved local control, especially in tumors with high-risk features like spread through air spaces (STAS). Limitations of wedge resection include inconsistent margins, suboptimal lymph node evaluation, and variability in technical quality. Emerging technologies and non-surgical alternatives, such as stereotactic body radiation therapy (SBRT), radiofrequency ablation (RFA), and particularly microwave ablation (MWA), offer new perspectives for high-risk patients. Conclusions: Wedge resection remains a valuable option in select patients with early-stage NSCLC, though its role continues to be redefined. Future integration of radiomics, intelligence (AI), and molecular profiling may enhance patient selection and refine surgical decision-making, potentially reshaping the place of wedge resection within personalized treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.